Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant - Saito, Akatsuki; Tamura, Tomokazu; Zahradnik, Jiri; Deguchi, Sayaka; Tabata, Koshiro; Anraku, Yuki; Kimura, Izumi; Ito, Jumpei; Yamasoba, Daichi; Nasser, Hesham; Toyoda, Mako; Nagata, Kayoko; et al. (Cell host & microbe, 2022)
Keywords: Antibodies, Neutralizing; Antibodies, Viral; Antiviral Agents - pharmacology; Antiviral Agents - therapeutic use; antiviral drug resistance; BA.2.75; COVID-19; COVID-19 Serotherapy; Humans; immune resistance; Omicron; pathogenicity; SARS-CoV-2; SARS-CoV-2 - genetics; Spike Glycoprotein, Coronavirus - genetics; transmissibility; COVID-19; pathogenicity; SARS-CoV-2; transmissibility; immune resistance; antiviral drug resistance; Omicron; BA.2.75